ReShape Lifesciences Inc.

0.39
-0.05 (-11.46%)
At close: Mar 28, 2025, 3:59 PM
0.39
1.81%
After-hours: Mar 28, 2025, 06:57 PM EDT

ReShape Lifesciences Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY03
Cash & Equivalents 4.46M 3.85M 22.77M 2.96M 2.94M 5.55M 10.16M 3.31M 7.93M 11.62M 23.3M 22.31M 28.49M 30.84M 14.62M 21.06M 48.73M 17.54M 10.72M n/a
Short-Term Investments n/a n/a n/a n/a n/a 2.55M 23.29M 2.5M 9.18M n/a n/a n/a 1.01M n/a n/a 5.24M 8.3M 17.2M n/a n/a
Long-Term Investments n/a n/a -555K -2.65M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 29K 46K 1.46M 46K 99K 562.86K 989K 1.12M 759K 880K 822K 1.08M 288.98K 140K 146K 220.91K 5K 6.39K 36.56K n/a
Receivables 1.66M 2.18M 2.81M 2.62M 4.1M 917K 488.61K 143.69K 57.93K 2.81K n/a 52.41K n/a n/a 10.01K 77.27K 96.31K 155.52K 21.6K n/a
Inventory 3.74M 3.61M 3M 2.24M 1.32M 984.74K 2.82M 1.79M 1.69M 981K 1.13M 1.27M 1.07M n/a -14.14M n/a n/a n/a n/a n/a
Other Current Assets 437K 265K 1.35M 1.12M 1.76M 1.27M 1.32M 476.94K 830.51K 421.5K 546.74K 771.65K 1M 6.96M 474.34K 421.82K 426.72K 67.65K 141.64K n/a
Total Current Assets 10.3M 9.91M 30.25M 8.94M 10.11M 8.72M 13.94M 5.72M 10.5M 13.02M 24.99M 24.4M 31.57M 37.8M 15.1M 26.79M 57.55M 34.96M 10.88M n/a
Property-Plant & Equipment 310K 869K 1.72M 1.05M 774K 63.55K 439K 201K 326K 482K 577K 610K 630.35K 742K 966K 1.26M 1.49M 1.1M 642.55K n/a
Goodwill & Intangibles n/a 260K 20.83M 27.02M 28.67M 36.93M 73.34M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 367K 1.23M 24M 28.12M 29.55M 37.55M 74.77M 1.32M 1.08M 1.36M 1.4M 1.69M 919.33K 882K 1.11M 1.48M 1.5M 1.11M 679.11K n/a
Total Assets 10.66M 11.14M 54.26M 37.06M 39.66M 46.27M 88.7M 7.04M 11.59M 14.39M 26.39M 26.1M 32.49M 38.69M 16.21M 28.28M 59.05M 36.06M 11.56M 717K
Account Payables 1.69M 1.93M 3.47M 3.65M 4.26M 1.63M 1.09M 1.31M 172.05K 399.34K 127.33K 340.56K 434.44K 125.19K 33.62K 163.38K 300.34K 678.76K 316.85K n/a
Deferred Revenue 44K 510K 549K 398K 202K 352K 510K n/a -549.56K -4.35M -8.71M -445 n/a -2.95M -6.25M n/a n/a n/a n/a n/a
Short-Term Debt 111K 342K 558K 3.92M 291K 9.93M 1.96M n/a 717.39K 2.98M 4M 3M 2.31M 922K 3.88M 2.67M 5.08M 2.65M 998.05K n/a
Other Current Liabilities 1.87M 5.09M 3.2M 3.76M 5.46M -3.55M 3.49M 294.00 3.6M -500 -4M 4.2M 6.82M 2.95M -3.88M 3.04M 2.37M 1.7M 927.13K n/a
Total Current Liabilities 3.78M 7.48M 7.33M 11.61M 10.39M 8.36M 1.09M 1.31M 4.49M 3.38M 127K 7.54M 9.56M 6.03M 34K 5.88M 7.75M 5.03M 2.24M n/a
Long-Term Debt 151K n/a n/a 9.33M 477K n/a 7.96M 9.88M 549.79K n/a 2.87M 6.68M 2.88M 4.98M 3.88M 11M 6.02M 1.73M 7.34M n/a
Other Long-Term Liabilities 72K -123K 855K 1.64M 4.68M 6.25M -2.67M -9.84M 2.88M n/a 8.71M n/a n/a -2.03M 6.72M n/a n/a 728.84K n/a n/a
Total Long-Term Liabilities 223K 2.61M 855K 10.97M 5.16M 6.25M 11.25M 2.79M 3.43M 4.35M 11.58M 6.68M 2.88M 2.95M 10.6M 11M 6.02M 2.46M 7.34M n/a
Total Liabilities 4M 7.48M 8.19M 22.57M 15.55M 14.61M 12.34M 4.1M 7.91M 7.72M 11.71M 14.22M 12.44M 8.98M 10.63M 16.87M 13.77M 7.49M 9.59M 1.39M
Total Debt 262K 171K 279K 477K 768K 6.31M 488.61K 143.69K 1.27M 2.98M 6.87M 9.68M 5.19M 5.91M 7.76M 13.67M 11.1M 4.38M 8.34M n/a
Common Stock 23K 1K 18K 6K 8K 87.7K 309.57K 27.37K 71.64K 695.7K 635.51K 418.43K 367.53K 278.92K 373.78K 169K 167.99K 5.8K 4.8K n/a
Retained Earnings -635.57M -624.19M -576.76M -514.83M -493.2M -418.99M -334.76M -300.94M -277.58M -252.08M -225.95M -200.17M -176.71M -150.71M -133.37M -101.31M -63.43M -34.86M -17.17M -2.5M
Comprehensive Income -88K -88K -92K -121K -8K -3.14M -2.97M -2.76M -2.62M -2.43M -2.24M n/a 692.00 -1.57M n/a 12.99K -41.67K -66.48K -87.53K n/a
Shareholders Equity 6.66M 3.66M 46.07M 14.49M 24.11M 31.66M 76.37M 2.94M 3.67M 6.66M 14.68M 11.88M 20.04M 29.71M 5.58M 11.41M 45.28M 28.57M 1.97M -670K
Total Investments n/a n/a -555K -2.65M n/a 2.55M 23.29M 2.5M 9.18M n/a n/a n/a 1.01M n/a n/a 5.24M 8.3M 17.2M n/a n/a